Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TargetCaRe

Financiado

Targeting Cartilage Regeneration in joint and intervertebral disc diseases

Mobility, important for well-being, is seriously impaired by chronic low back pain and osteoarthritis in many people due to degeneration of cartilaginous tissue of the intervertebral disc and joint. To develop a treatment for thes... ver más

28/02/2019

ERASMUS MC

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 13 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-02-28

MSCA-ITN-2014-ETN: Marie Skłodowska-Curie Innovative T... Scope:European Training Networks (ETN)

I+D

Cerrada hace 10 años

0% 100%

13 Participantes

ERASMUS MC

510.75K€ | Lider

TECNICAS MODULARES E INDUSTR...

127.65K€ | Participante

TECHNION ISRAEL INSTITUTE O...

520.60K€ | Participante

CARDIFF UNIVERSITY

273.29K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PGC2018-102047-B-I00 ANDAMIOS BIOHIBRIDOS ASOCIADOS CON APATITOS NANOCRISTALINOS... 133K€ Cerrado

CARTHAGO Cartilaginous tissue regeneration by non viral gene therapy... 4M€ Cerrado

PCIN-2015-113 NANOESTRUCTURAS DISEÑADAS PARA TERAPIAS CELULARES AVANZADAS 150K€ Cerrado

PCIN-2015-261 NANOCOMPOSITES JERARQUICOS DOPADOS IONICAMENTE COMO SOPORTES... 110K€ Cerrado

RTC-2016-5451-1 DESARROLLO DE SISTEMAS DE BIOIMPRESIÓN Y BIOTINTAS PARA REGE... 204K€ Cerrado

RESTORE User centred smart nanobiomaterial based 3D matrices for cho... 6M€ Cerrado

Duración del proyecto: 50 meses Fecha Inicio: 2014-12-05
Fecha Fin: 2019-02-28

Líder del proyecto

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDA... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Descripción del proyecto Mobility, important for well-being, is seriously impaired by chronic low back pain and osteoarthritis in many people due to degeneration of cartilaginous tissue of the intervertebral disc and joint. To develop a treatment for these diseases this ETN aims to combine expertise in novel highly advanced drug delivery carriers with dedicated targeting tools, state of the art imaging techniques and expertise in stem cell and joint biology by training 15 young scientists in 12 partner institutes located in 5 different countries. We aim to achieve regeneration of damaged and degenerated tissues by employing targeting strategies tailored both to the pathology and the tissues involved. Regeneration of diseased tissues will be achieved by loading biologically active agents in state-of-the-art nanocarriers. The biologically active agents will stimulate the body’s own capacity to regenerate by attracting local stem cells or inhibit degeneration. Targeting will be achieved by A] injection with synthetic or natural hydrogels loaded with the nanocarriers or B] coupling diseased tissue-specific antibodies and specific hyaluronic acid moieties to the nanocarriers. Delivery and retention will be monitored by advanced in vivo and molecular imaging techniques to monitor distribution of the delivered compounds at the tissue level, as well as detect biological markers of regeneration. Major objectives: 1] To establish a network of scientists skilled in the use of smart nanocarriers, unique approach of targeting by disease-specific molecules and application of innovative imaging tools. Supported by generic scientific and training in economical and clinical valorisation, these researchers can further implement these technologies in the musculoskeletal or other areas, both in academia and industry. 2] To develop strategies exclusively targeting diseased tissues with controlled doses of bio-actives, circumventing the disadvantages of the current shotgun approaches in regenerative medicine.

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores